FDA Actions in Brief April 2012

Recent FDA Approvals (through March 2012) related to (Bayer HealthCare Pharmaceuticals, Biogen Idec, Medimmune, EffRx Pharmaceuticals, Aptalis, Teva, Organogenesis)

Full Story →